Cambridge Investment Research Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,322,759
| Closed | -$913K | – | 3033 |
|
|
2020
Q4 | $913K | Sell |
1,322,759
-60,193
| -4% | -$41.5K | 0.01% | 1371 |
|
|
2020
Q3 | $3.11M | Buy |
1,382,952
+1,248,713
| +930% | +$2.81M | 0.02% | 602 |
|
|
2020
Q2 | $481K | Sell |
134,239
-152
| -0.1% | -$545 | ﹤0.01% | 1577 |
|
|
2020
Q1 | $511K | Buy |
134,391
+5,248
| +4% | +$20K | ﹤0.01% | 1354 |
|
|
2019
Q4 | $389K | Buy |
+129,143
| New | +$389K | ﹤0.01% | 1744 |
|